Clinical Trials Directory

Trials / Unknown

UnknownNCT04417608

Looking for Minimum Dose to Induce Sympathectomy in Infraclavicular Brachial Plexus Block

Status
Unknown
Phase
Study type
Observational
Enrollment
66 (estimated)
Sponsor
Taipei Medical University WanFang Hospital · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

For patients who undergoing hemodialysis, it is important to have good AV fistula. One third of AV fistula usually fail during early stage. It is helpful to use nerve block to dilate the blood vessels and enhance the prognosis. But 0.2% Ropivacaine usually cause muscle weakness in present studies. The investigators hope to find the lowest concentration to provide sympathectomy without muscle weakness. Because the patients with hemodialysis usually have multiple co-morbidity, thus we choose patients with forearm fracture at the first place. With this result, the investigators can design further study for patients with hemodialysis. The investigators prefer proximal approach because brachial plexus run together in the cosctoclavicular space and show lower incidence of incomplete work.

Conditions

Interventions

TypeNameDescription
PROCEDUREInfraclavicular brachial plexus blockUltrasound-guided infraclavicular brachial plexus block

Timeline

Start date
2020-06-04
Primary completion
2021-07-04
Completion
2021-07-04
First posted
2020-06-04
Last updated
2020-06-04

Source: ClinicalTrials.gov record NCT04417608. Inclusion in this directory is not an endorsement.

Looking for Minimum Dose to Induce Sympathectomy in Infraclavicular Brachial Plexus Block (NCT04417608) · Clinical Trials Directory